Every Week, the Editor-in-Chief selects an Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full article, which is freely available to all readers for at least 30 days from the time of this post. In addition to the […]
Association between type 2 diabetes, curative treatment and survival in men with intermediate- and high-risk localized prostate cancer Abstract Objective To investigate whether curative prostate cancer (PCa) treatment was received less often by men with both PCa and Type 2 diabetes mellitus (T2DM) as little is known about the influence of T2DM diagnosis on […]
This month, BJUI continues the Four Seasons Peer Reviewer Award recognising the hard work and dedication of our peer reviewers. Each quarter the Editor and Editorial Team will select an individual peer reviewer whose reviews over the last 3 months have stood out for their quality and timeliness. The Winter Crown goes to Jose A. […]
Every Week, the Editor-in-Chief selects an Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full article, which is freely available to all readers for at least 30 days from the time of this post. In addition to the […]
This image is taken from Park et al, BJUI 2017
This issue’s article of the month, Does RARP benefit patients with oligometastatic PCa?, is from Seoul, South Korea. The cover image shows Seoul Tower, a communication and observation tower located on Namsan Mountain. At 236m, it marks the second highest point in Seoul. Tower ©istock.com/tawatchaiprakobkit Click here for this issue’s […]
Every Month, the Editor-in-Chief selects an Article of the Month from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full article, which is freely available to all readers for at least 30 days from the time of this post. In addition to the […]
In this issue of BJU International, Jang et al. [1] investigate the perioperative and oncological outcomes of robot-assisted radical prostatectomy (RARP) in oligometastatic prostate cancer. The authors evaluated a retrospective cohort of 79 patients with oligometastatic prostate cancer, defined as up to five bony metastases on bone scan without visceral metastasis on conventional CT, treated either with RARP (n = […]